30
Views
11
CrossRef citations to date
0
Altmetric
Article

Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study

, , , &
Pages 245-254 | Received 08 Aug 2003, Accepted 01 Mar 2004, Published online: 08 Jul 2009

References

  • Sans S, Kesteloot H, Kromhout D, on behalf of the Task Force. The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology and Cardiovascular Mor-tality and Morbidity Statistics. Eur Heart J 1997; 18: 1231–48.
  • Baburin A, Gornoi K, Leinsalu M, Rahu M. Atlas of mortality in Estonia. Tallinn, Estonia: Printall; 1997.
  • Volol O, Kaup R, Abina J, Solodkaja E, Kalyuste T, Goldsteine G, Olferiev A, Deev A. Lipid disorders and their changes in postsocialist Estonia. J Clin Basic Cardiol 1999; 2: 249— 53.
  • Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, De Backer G. Cor-onary heart disease/myocardial infarction: plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation 1994; 89: 1967–73.
  • Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Quinci GB. Lipoprotein Lp(a) and the risk of myocardial infarction. Atherosclerosis 1981; 38: 51–61.
  • Dahlen GM, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein(a), plasma lipids and other lipopro-teins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65.
  • Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. Br Med J 1990; 301: 1248–51.
  • Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67.
  • Ridker P, Hennekens C, Stampfer M. A prospec-tive study of lipoprotein(a) and risk of future myocardial infarction. J Am Med Assoc 1993; 270: 2195–9.
  • Boerwinkle E, Leffert CC, Lin J, Lacner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52–60.
  • Vella JC, Calmarza P, Goni M, Berzosa J. Lipoprotein(a) and other lipidic parameters in newborns from Burgos, Spain. Atherosclerosis 1997; 134: 384.
  • Czinner A, Bihari V-M, Gruber E. Racial (gipsy/ white) difference in serum Lp(a) levels and its relation to familial risk for atherosclerosis. Ather-osclerosis 1994; 109: 286.
  • Behrman RE, Vaughan VC, Nelson WE. Nelson Textbook of pediatrics. 13th ed. Philadelphia: W.B. Saunders Company; 1987.
  • Friedewald WT, Levy RJ, Fredricson DS. Estima-tion of the concentration of low density lipopro-tein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499— 502.
  • Sundvall J, Sulonen G-B, Hiltunen O, Kiuru J, Pursiainen M, Jauhiainen M. Comparison of a new immunoturbidimetric assay of human serum lipoprotein(a) to the ELISA and the IRMA methods. Scand J Clin Lab Invest 1995; 55: 171–80.
  • Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein levels. The Framingham Off-spring Study. Circulation 1993; 87: 1135–41.
  • Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing anti-bodies. Anal Biochem 1966; 15: 45–52.
  • Riepponen P, Marniemi J, Rautaoja T. Immuno-turbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987; 47: 739–44.
  • Assmann G, Schulte H. European lipid guidelines: therapeutic recommendations. Am J Cardiol 1989; 63: 53H–5H.
  • MedCalc for Windows. Statistics for Biomedical Research. Copyright© 1993–1999, Frank Schoon-jans, Belgium.
  • Abramson JH, Gahlinger PM. Computer pro-grams for epidemiologists: PEPI Version 3. London: Brixton Books; 1999. /www.usd-inc.com/ pepi.html/
  • Gotto AM, Assmann G, Carmena R, Davignon J, Fernandez-Cruz A, Fruchart J-C, Kastelein JJP, Paoletti R. Advisory board/writing group. The international lipid information bureau lipid hand-book for clinical practice. Blood lipids and coronary heart disease. 2nd ed. New York: International Lipid Information Bureau, USA. 2000.
  • Yamamoto A, Horibe H, Mabuchi H, Kita T, Matsuzava Y, Saito Y, Nakaya N, Fujioka T, Tenba H, Kawaguchi A, Nakamura H, Goto Y, for the Research Group on Serum Lipid Survey 1990 in Japan. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postme-nopausal women. Atherosclerosis 1999; 143: 55–73.
  • Valdivielso P, Martinez-Cortéz F, Legros JR, Vadillo J, Martin-Sanchez JM, Torres E, Martinez-Guerrero MV. Lipids and lipoproteins in cord blood: analyses of a Hispanic and Arab population. Acta Pxdiatr 1992; 81: 439–40.
  • Bellü R, Ortisi MT, Agostoni C, Incerti P, Besana R, Riva E, Giovannini M. Familial history of cardiovascular disease and blood lipid pattern in newborn infants. Acta Pxdiatr 1992; 81: 21–4.
  • Loughrey CM, Rimm E, Heiss G, Rifai N. Race and gender differences in cord blood lipoproteins. Atherosclerosis 2000; 148: 57–65.
  • Casanueva V, Cid X, Chiang MT, Molina M, Ferrada MC, Perez R, Casanueva P. Lipidos, lipoproteinas y apolipoproteinas en recien nacidos normales. Revista Medica de Chile 1998; 126: 1073–8.
  • Andoh T, Uda H, Yoshimitsu N, Hatano H, Ueda T, Iwamatsu Y, Akiba S. The sex differences in cord-blood cholesterol and fatty-acid levels among Japanese fetuses. J Epidemiol 1997; 7: 226–31.
  • Parker CR Jr, Fortunato SJ, Carr BR, Owen J, Hankins GD, Hauth JC. Apolipoprotein A-I in umbilical cord blood of newborn infants: relation to gestational age and high-density lipoprotein cholesterol. Pediatr Res 1988; 23: 348–51.
  • Lane DM, McConathy WJ, McCaffree MA, Hall M. Cord serum lipid and apolipoprotein levels in preterm infants with the neonatal respiratory distress syndrome. J Maternal-fetal Neonat Med 2002; 11: 118–25.
  • Furuhashi N, Suzuki M, Fukaya T, Kono H, Shinkawa O, Tachibana Y, Takahashi T. Con-centration of luteinizing hormone—human chor-ionic gonadotropin, beta subunit of human chorionic gonadotropin, follicle-stimulating hor-mone, estradiol, cortizole, and testosterone in cord sera and their correlations. Am J Obstet Gynecol 1982; 143: 918–21.
  • Chan L, Boerwinkle E, Wen-Hsiung Li. Molecular genetics of the plasma apolipoproteins. In: Chien S, editor. Molecular biology of the cardiovascular system. Lea & Febiger; Philadelphia & London 1990. p. 183–219.
  • Averna MR, Barbagallo CM, Di Paola G, Labisi M, Pinna G, Marino G, Dimita U, Notarbartolo A. Lipids, lipoproteins and apolipoproteins Al, All, B, CII, CIII and E in newborns. Biol Neonate 1991; 60: 187–92.
  • Herrmann W, Hanf S, Kaffarnik H, Motzny S, Reissner J, Steinmetz A. The influence of apoli-poprotein B and A-I during the first year of life. Am Acad Pediatr 1994; 93: 296–302.
  • Shimura Y, Tanaka T, Ohtani H. Lipoprotein(a) concentrations and apolipoprotein(a) phenotype frequencies in cord blood of newborn infants and sera of children in Japan [in Japanese]. Rinsho Byori—Jpn J Clin Pathol 1997; 45: 255–9.
  • Routi T, Rönnemaa T, Jokinen E, Viikari J, Niinikoski H, Leino A, Simell O. Correlation of toddlers' serum lipoprotein(a) concentration with parental values and grandparents' coronary heart disease: the STRIP baby study. Acta Pxdiatr 1996; 85: 407–12.
  • Neary RH, Kilby MD, Kumpatula P, Game FL, Bhatnagar D, Durrington PN, O'Brien PMS. Fetal and maternal lipoprotein metabolism in human pregnancy. Clin Sci 1995; 88: 311–8.
  • Aasvee K, Jauhiainen M, Kurvinen E, Jordania R, Sundvall J, Ehnholm C. Lipoprotein(a), apolipo-protein A-I and B serum levels in young families from Tallinn, Estonia. Scand J Clin Lab Invest 1999; 59: 179–89.
  • Braeckman L, De Bacquer D, Rosseneu M, De Backer G. Determinants of lipoprotein(a) levels in a middle-aged working population. Eur Heart J 1996; 17: 1808–13.
  • Klausen IC, Beisiegel U, Menzel H-J, Rosseneu M, Nicaud V, Faergeman O, on behalf of the EARS Group. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. Arterioscler Thromb Vasc Biol 1995; 15: 1001–8.
  • Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, Boerwinkle E, Hills LD, Hobbs HH. No association between plasma lipoprotein(a) concentration and the presence or absence of coronary atherosclerosis in Afro-Americans. Arterioscler Thromb Vasc Biol 1995; 15: 850–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.